Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Incyte Corp

Incyte Corp reported $29.7M in Loan Capital for its fiscal quarter ending in March of 2023.

Loan Capital Change
Agenus AGEN:US USD 12.63M 43K
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
Amgen AMGN:US USD 60.76B 23.41B
Biogen BIIB:US USD 6.28B 1.7M
BioMarin Pharmaceutical BMRN:US USD 1.08B 803K
CTI Biopharma CTIC:US USD 68.37M 7.24M
Eli Lilly LLY:US USD 18.88B 4.14B
Incyte Corp INCY:US USD 29.7M 384K
Intercept Pharmaceuticals ICPT:US USD 223.35M 248K
Ionis Pharmaceuticals IONS:US USD 1.18B 1.66M
Moderna Inc MRNA:US USD 831M 81M
Novartis NOVN:VX USD 21.99B 203M
Novartis NVS:US USD 21.99B 203M
PTC Therapeutics PTCT:US USD 1.25B 21.18M
Puma Biotechnology PBYI:US USD 98.62M 316K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
Vertex Pharmaceuticals VRTX:US USD 417.6M 13.2M